Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
Here’s your guide to this week’s kid trends, including “Steal a Brainrot,” heavy soda, fake Polaroids, $1,000 rocks, and a robot cowboy called Rizzbot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback